EULAV Asset Management Grows Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

EULAV Asset Management lifted its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 4.4% in the 3rd quarter, Holdings Channel.com reports. The firm owned 309,000 shares of the medical research company’s stock after purchasing an additional 13,000 shares during the period. IQVIA comprises about 1.8% of EULAV Asset Management’s holdings, making the stock its 15th largest position. EULAV Asset Management’s holdings in IQVIA were worth $73,224,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the company. First Foundation Advisors lifted its position in IQVIA by 3.8% in the second quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock valued at $245,000 after acquiring an additional 43 shares during the last quarter. Invera Wealth Advisors LLC lifted its position in IQVIA by 0.3% in the second quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock valued at $3,183,000 after acquiring an additional 46 shares during the last quarter. Covestor Ltd lifted its position in IQVIA by 45.3% in the first quarter. Covestor Ltd now owns 154 shares of the medical research company’s stock valued at $39,000 after acquiring an additional 48 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in IQVIA by 0.3% in the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock valued at $3,313,000 after acquiring an additional 48 shares during the last quarter. Finally, Continuum Advisory LLC lifted its position in IQVIA by 3.3% in the second quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company’s stock valued at $325,000 after acquiring an additional 49 shares during the last quarter. 89.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at IQVIA

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the company’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total value of $320,229.00. Following the sale, the insider now owns 19,536 shares of the company’s stock, valued at $4,812,302.88. This represents a 6.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Leerink Partners restated an “outperform” rating and issued a $248.00 price objective (down from $260.00) on shares of IQVIA in a research note on Tuesday. StockNews.com lowered shares of IQVIA from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Truist Financial dropped their price objective on shares of IQVIA from $286.00 to $265.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Finally, Robert W. Baird dropped their price objective on shares of IQVIA from $256.00 to $223.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $256.50.

IQVIA Stock Up 0.2 %

IQV stock opened at $191.33 on Wednesday. IQVIA Holdings Inc. has a 52 week low of $187.62 and a 52 week high of $261.73. The company has a market cap of $34.73 billion, a P/E ratio of 25.11, a P/E/G ratio of 1.98 and a beta of 1.51. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The company’s 50-day moving average price is $225.08 and its 200 day moving average price is $227.79.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.